Thu, Jan 29, 2015, 11:34 AM EST - U.S. Markets close in 4 hrs 26 mins

Recent

% | $
Quotes you view appear here for quick access.

Titan Pharmaceuticals Inc. Message Board

  • seniorpuff21 seniorpuff21 Jan 26, 2013 1:07 PM Flag

    Ambs cure for parkinsons

    As a long time holder of Ttnp and srpt I feel the need to tell everyone about Ambs. Huge potential and in the early stages of development with one of the former founders of Amgen on the board and a recent insider purchase by the CEO only good things can happen from here.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • As a long time holder of Ttnp, why did you suddenly feel the need to "create your alias" just today?
      Do you really feel that you have ANY credibility here? Please stop! Please?!

      Sentiment: Strong Buy

      • 1 Reply to jttarbel
      • Well I kind of got stuck back in September when I bought 5500 shares at a $1.02 average of Ttnp and it tanked shortly after but I held on because I believe in the idea. This stock reminds me of the way arna has traded over the last year and I expect it to pop just like arna. I have gotten some good tips off some of these boards like srpt right before it tripled. As far as creating my alias today, they do time out every two weeks if you don't change the setting. And as far as Ambs, I have a friend that told me about it back in December, and I have done very well with it. Like any start up biotech there is never enough money and almost always dilution , but this company has potential to have a possible cure for a disease that has none, and for a former founder of Amgen to be on the board of advisors makes me believe the drug must have potential. And the CEO just purchased some stock himself on 1/11/13, and that is always a good sign.

        Sentiment: Strong Buy

    • You're joking right?

      AMBS had $480.00 cash in September and $5M of liabilities.
      Hey, I have more than $480.00 in my pocket right now.
      They're in default on their debt.

      Do they even own anything related to Parkinson's?
      They have tons of lawsuits, one of them is related to the IP for Parkinson's (see below):

      "On January 6, 2012 the Company was served a summons regarding the filing of a lawsuit (Complaint for Breach of Contract, Specific Performance and Common Counts) against the Company by a former consultant to the Company, Peter Freeman v. Amarantus Biosciences, Inc. The Company intends to defend ourselves vigorously. The Company is unable to predict the likelihood of an unfavorable outcome or estimate its potential liability, if any, and no provision has been made in its financial statements for this matter. In August, 2012, the company reached a settlement with Mr. Freeman whereby he will receive payment of $44,000 in monthly installments of $5,000 until fully paid.

      On August 8, 2012 the Company was served a summons regarding the filing of a lawsuit (Complaint for Breach of Contract) against the Company by On Assignment Staffing Services, Inc., a temporary staffing agency, for outstanding debts of $36,414 allegedly due On Assignment Staffing Services, Inc.

      In addition the Company is in default on payment of certain Convertible Notes that were due as of December 6, 2011 and is also late with regard to making payments to various trade account vendors for goods and services received, of which some accounts are currently with collection agencies and could possibly result in lawsuits with the Company.

      Power3 Medical Products, Inc. (“Power3”) entered into a License Agreement with Amarantus BioSciences, Inc. (“our”, “us”, or “we”) on January 16, 2012 to, among other things, license the NuroPro diagnostic test for Parkinson's disease to us (the "Agreement"). As part of the Agreement, we were granted an option to acquire certain intellectual property, and a right of first refusal to acquire certain intellectual property (collectively the "IP"). We recently found out the Agreement was entered into at a time when Power3 may not have had the authority to enter into the Agreement.

      On June 26th, 2012, we became aware of a previously undisclosed legal dispute between Power3 and NeoGenomics, Inc. ("NeoGenomics") where certain intellectual property assets of Power3 were placed into receivership in September 2011 in the State of Texas as a result of an unpaid note to NeoGenomics. On June 15, 2012 Power3 filed for Chapter 7 bankruptcy. However, on June 7th, 2012, the receiver sold, among other things, Power3's IP to NeoGenomics. Although this sale may be considered a preference in the Power3 Bankruptcy, at this time NeoGenomics may have title to certain intellectual property of Power3."

 
TTNP.OB
0.4630.000(0.00%)Oct 30 2:14 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.